Frontier Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Frontier Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-367,876	Closed	-$17M	–	308
2019 Q2	$17M	Buy	367,876 +25,305	+7%	+$710K	0.13%	186
2019 Q1	$8.35M	Buy	+342,571	New	+$7.13M	0.06%	245

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Frontier Capital Management's ARRY Position: Q3 2019 in Review

Frontier Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 367,876 shares — an estimated $17M sold.

Frontier Capital Management first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $17M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Frontier Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Frontier Capital Management sold 367,876 Array Biopharma Inc shares in Q3 2019, an estimated $17M.
Frontier Capital Management first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
Frontier Capital Management's Array Biopharma Inc position peaked at $17M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Frontier Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.